Insulet shares are trading lower after the company announced a voluntary Medical Device Correction for specific lots of Omnipod 5, Omnipod DASH, and Omnipod Insulin Management System Pods due to a manufacturing issue. Also, BTIG lowered its price target on the stock from $260 to $235.